AtaiBeckley (ATAI) EBT Margin (2021 - 2026)
AtaiBeckley's (ATAI) quarterly EBT Margin came in at 3121.8% in Q1 2026, down 142991.0% year-on-year from N/an in Q1 2025, and down 84.51% quarter-over-quarter from 1691.9% in Q1 2025.
AtaiBeckley (ATAI) EBT Margin (2021 - 2026) Analysis & Trends
AtaiBeckley (ATAI) has 5 years of EBT Margin data on file, last reported at 8139.79% in Q3 2025.
- For the quarter ending Q3 2025, EBT Margin rose 5801771.0% year-over-year to 8139.79%; the trailing twelve-month figure through Sep 2025 stood at 5077.86% (up 3345417.0% YoY), and the FY2024 full-year result was 48183.44%, down 3567198.0% from the prior year.
- EBT Margin eased to 3121.8% in Q1 2026 per ATAI's latest filing, from 1691.9% in the prior quarter.
- Across five years, EBT Margin topped out at 1691.9% in Q1 2025 and bottomed at 3121.8% in Q1 2026.
- A 5-year average of 54835.77% and a median of 19656.57% in 2023 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin surged 18845718 bps in 2023 and slumped 22475556 bps in 2024, its largest moves.
- Tracing ATAI's EBT Margin over 5 years: stood at 21121.3% in 2021, then slumped by 390 bps to 103476.32% in 2022, then rose by 2 bps to 101777.78% in 2023, then tumbled by 221 bps to 326533.33% in 2024, then jumped by 98 bps to 8139.79% in 2025.
- Business Quant data shows ATAI's EBT Margin at 8139.79% in Q3 2025, 3846.04% in Q2 2025, and 1691.9% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - | -8,139.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,121.80% |
| Sep 30, 2025 | -8,139.79% |
| Jun 30, 2025 | -3,846.04% |
| Mar 31, 2025 | -1,691.90% |
| Mar 31, 2025 | -1,691.90% |
| Dec 31, 2024 | -326,533.33% |
| Sep 30, 2024 | -66,157.50% |
| Jun 30, 2024 | -20,907.33% |
| Dec 31, 2023 | -101,777.78% |
| Sep 30, 2023 | 50,398.85% |
| Jun 30, 2023 | -18,405.81% |
| Mar 31, 2023 | -89,610.81% |
| Dec 31, 2022 | -103,476.32% |
| Sep 30, 2022 | -138,058.33% |
| Jun 30, 2022 | -18,121.18% |
| Dec 31, 2021 | -21,121.30% |
| Sep 30, 2021 | -9,952.63% |
| Mar 31, 2021 | 28.94% |